These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18172820)

  • 21. Efficacy of Combined Ultrasound-and-Microbubbles-Mediated Diclofenac Gel Delivery to Enhance Transdermal Permeation in Adjuvant-Induced Rheumatoid Arthritis in the Rat.
    Liao AH; Chung HY; Chen WS; Yeh MK
    Ultrasound Med Biol; 2016 Aug; 42(8):1976-85. PubMed ID: 27181685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative evaluation of the safety and efficacy of etoricoxib and diclofenac on the upper gastrointestinal tract in patients with osteoarthrosis and rheumatoid arthritis (the multinational etoricoxib and diclofenac arthritis long-term (MEDAL) study program)].
    Alekseeva LI
    Ter Arkh; 2010; 82(8):57-62. PubMed ID: 20873248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antinociceptive effect of iontophoretic direct application of diclofenac to arthritic knee-joints of rats.
    Motta AF; Borges Junior NG; da Fonseca JC; Tonussi CR
    Life Sci; 2003 Aug; 73(15):1995-2004. PubMed ID: 12899924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of gelatin microspheres loaded with diclofenac sodium for intra-articular administration.
    Saravanan M; Bhaskar K; Maharajan G; Pillai KS
    J Drug Target; 2011 Feb; 19(2):96-103. PubMed ID: 20380621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomedicine for Intra-Articular Drug Delivery in Rheumatoid Arthritis.
    O'Mary H; Del Rincόn I; Cui Z
    Curr Med Chem; 2016; 23(23):2490-506. PubMed ID: 27237822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.
    Altman R; Bosch B; Brune K; Patrignani P; Young C
    Drugs; 2015 May; 75(8):859-77. PubMed ID: 25963327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
    Cannon CP; Curtis SP; Bolognese JA; Laine L;
    Am Heart J; 2006 Aug; 152(2):237-45. PubMed ID: 16875903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac.
    Yoshioka K; Kisukeda T; Zuinen R; Yasuda Y; Miyamoto K
    BMC Musculoskelet Disord; 2018 May; 19(1):157. PubMed ID: 29789008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of gastric ulcerogenicity during multiple administration of diclofenac sodium by a novel solid-in-oil suspension.
    Piao H; Hirata A; Yokoyama H; Fujii T; Shimizu I; Ito S; Kamiya N; Goto M
    Pharm Dev Technol; 2007; 12(3):321-5. PubMed ID: 17613895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes.
    Fujisawa T; Miyai H; Hironaka K; Tsukamoto T; Tahara K; Tozuka Y; Ito M; Takeuchi H
    Int J Pharm; 2012 Oct; 436(1-2):564-7. PubMed ID: 22828072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: does the topical patch really enhance a local treatment?
    Xi H; Cun D; Xiang R; Guan Y; Zhang Y; Li Y; Fang L
    J Control Release; 2013 Jul; 169(1-2):73-81. PubMed ID: 23567043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.
    Bianchi Porro G; Montrone F; Lazzaroni M; Manzionna G; Caruso I
    Ital J Gastroenterol Hepatol; 1999; 31(5):378-85. PubMed ID: 10470596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral delivery of diclofenac sodium using a novel solid-in-oil suspension.
    Piao H; Kamiya N; Watanabe J; Yokoyama H; Hirata A; Fujii T; Shimizu I; Ito S; Goto M
    Int J Pharm; 2006 Apr; 313(1-2):159-62. PubMed ID: 16530362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis.
    Pawar VA; Manjappa AS; Murumkar PR; Gajaria TK; Devkar RV; Mishra AK; Yadav MR
    Eur J Pharm Sci; 2018 Dec; 125():11-22. PubMed ID: 30219410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment.
    Arias JL; López-Viota M; López-Viota J; Delgado AV
    Int J Pharm; 2009 Dec; 382(1-2):270-6. PubMed ID: 19712736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical nanocarriers for management of Rheumatoid Arthritis: A review.
    Anita C; Munira M; Mural Q; Shaily L
    Biomed Pharmacother; 2021 Sep; 141():111880. PubMed ID: 34328101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
    Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diclofenac/misoprostol: the European clinical experience.
    McKenna F
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis.
    Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA
    Int J Tissue React; 2005; 27(1):15-21. PubMed ID: 15847101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.